Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px

Financing › Details

Joimax–Hopp Group: investment, 201812 existent investment dievini Hopp owns 85% of Joimax GmbH

	Period	2018-12-05
	Money taker	Joimax GmbH
	Group	HOPP Group (family of Dietmar Hopp)
	Money source	Dievini Hopp BioTech Holding GmbH & Co. KG
	Group	HOPP Group (family of Dietmar Hopp)
	Product	endoscopy
	Product 2	venture capital
	Person	Hopp, Dietmar (SAP)
	Source	Hofmann, Siegfried / Brors, Peter. (12/5/18). "News: Interview – Dietmar Hopp glaubt an seine Biotechs – »Wir werden unseren Einsatz verdreifachen«".

Record changed: 2018-12-07

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for HOPP Group (family of Dietmar Hopp)

[1] AaviGen GmbH. (7/26/23). "Press Release: AaviGen Raises 17 Million € in Second Financing Round to Advance Precision Gene Therapies for Heart Failure towards the Clinical Stage". Heidelberg....
[2] Heidelberg Pharma AG. (2/17/22). "Press Release: Heidelberg Pharma AG Secures Financing Commitment From its Main Shareholder dievini (ad hoc)". Ladenburg....
[3] CureVac B.V.. (8/18/20). "Press Release: CureVac Announces Closing of Initial Public Offering". Tübingen & Boston, MA....
[4] Heidelberg Pharma AG. (4/27/20). "Press Release: Heidelberg Pharma AG Raises EUR 14.4 Million from Private Placement". Ladenburg....
[5] dievini Hopp BioTech holding GmbH & Co. KG. (3/15/20). "Press Release: dievini nimmt Stellung zu Presseveröffentlichungen über ihre Beteiligungsgesellschaft". Walldorf....
[6] Heidelberg Pharma AG. (1/22/20). "Press Release: Heidelberg Pharma AG Secures Financing Commitment from Its Main Shareholder Dievini". Ladenburg....
[7] CRS Clinical Research Services Andernach GmbH. (4/19/19). "Press Release: Management Buy-Out at CRS. Apleonex AG Buys LTS AG’s Shares in CRS Clinical Research Services Andernach GmbH". Andernach....
[8] Hofmann, Siegfried / Brors, Peter. (12/5/18). "News: Interview – Dietmar Hopp glaubt an seine Biotechs – »Wir werden unseren Einsatz verdreifachen«"....
[9] CureVac AG. (5/8/18). "Press Release: CureVac Announces New Management Structure. Founder Ingmar Hoerr to Transition to Chairman role; Daniel Menichella to Become CEO". Tübingen....
[10] BRAIN AG. (12/15/17). "Press Release: BRAIN Achieves Clear Improvement in Revenues and Earnings in the 2016/17 Financial Year". Zwingenberg....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]